Zoldakova M, Novotny M, Khakurel K, Zoldak G
Molecules. 2025; 30(2).
PMID: 39860253
PMC: 11767434.
DOI: 10.3390/molecules30020385.
Li H, Wang J, Rong L, Li J, Xue Y, Fang Y
J Mol Med (Berl). 2025; 103(3):265-271.
PMID: 39836218
DOI: 10.1007/s00109-025-02514-3.
Ge Y, Xie J, Liao Y, Xie L, Yang L
Front Genet. 2024; 15:1457248.
PMID: 39301525
PMC: 11410688.
DOI: 10.3389/fgene.2024.1457248.
Meloni A, Pistoia L, Ricchi P, Longo F, Cecinati V, Sorrentino F
J Clin Med. 2024; 13(16).
PMID: 39200932
PMC: 11355279.
DOI: 10.3390/jcm13164791.
von Brackel F, Oheim R
JBMR Plus. 2024; 8(8):ziae064.
PMID: 38957399
PMC: 11215550.
DOI: 10.1093/jbmrpl/ziae064.
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.
Meloni A, Pistoia L, Ricchi P, Longo F, Cecinati V, Sorrentino F
Radiol Med. 2024; 129(6):879-889.
PMID: 38683500
DOI: 10.1007/s11547-024-01821-y.
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.
Meloni A, Pistoia L, Ricchi P, Bagnato S, Longo F, Messina G
Ann Hematol. 2024; 103(6):1887-1896.
PMID: 38581547
DOI: 10.1007/s00277-024-05741-9.
Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance.
Meloni A, Parravano M, Pistoia L, Cossu A, Grassedonio E, Renne S
J Clin Med. 2023; 12(21).
PMID: 37959172
PMC: 10647397.
DOI: 10.3390/jcm12216706.
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience.
Meloni A, Pistoia L, Lupi A, Righi R, Vallone A, Missere M
Tomography. 2023; 9(5):1711-1722.
PMID: 37736989
PMC: 10514849.
DOI: 10.3390/tomography9050136.
Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy.
Ricchi P, Meloni A, Pistoia L, Gamberini M, Cuccia L, Allo M
Blood Transfus. 2023; 22(1):75-85.
PMID: 37146300
PMC: 10812892.
DOI: 10.2450/BloodTransfus.485.
The gene spectrum of thalassemia in Yangjiang of western Guangdong Province.
Liang H, Liang W, Xie W, Lin F, Liu L, Li L
Front Genet. 2023; 14:1126099.
PMID: 36861132
PMC: 9968962.
DOI: 10.3389/fgene.2023.1126099.
A Novel Tool for the Analysis and Detection of Copy Number Variants Associated with Haemoglobinopathies.
Minaidou A, Tamana S, Stephanou C, Xenophontos M, Harteveld C, Bento C
Int J Mol Sci. 2022; 23(24).
PMID: 36555557
PMC: 9782104.
DOI: 10.3390/ijms232415920.
Clinical validation of a single-tube PCR and reverse dot blot assay for detection of common α-thalassaemia and β-thalassaemia in Chinese.
Liang H, Li L, Yang H, Zheng X, Lu M, Ge Y
J Int Med Res. 2022; 50(2):3000605221078785.
PMID: 35225055
PMC: 8894620.
DOI: 10.1177/03000605221078785.
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major.
Pellegrino F, Zatelli M, Bondanelli M, Carnevale A, Cittanti C, Fortini M
Endocrine. 2019; 65(3):469-482.
PMID: 31300960
DOI: 10.1007/s12020-019-02003-x.
Influence of Iron on Bone Homeostasis.
Balogh E, Paragh G, Jeney V
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30340370
PMC: 6316285.
DOI: 10.3390/ph11040107.
Iron Absorption in Iron-Deficient Women, Who Received 65 mg Fe with an Indonesian Breakfast, Is Much Better from NaFe(III)EDTA than from Fe(II)SO₄, with an Acceptable Increase of Plasma NTBI. A Randomized Clinical Trial.
Ginanjar E, Indrawati L, Setianingsih I, Atmakusumah D, Harahap A, Timan I
Pharmaceuticals (Basel). 2018; 11(3).
PMID: 30201907
PMC: 6161297.
DOI: 10.3390/ph11030085.
On the Mechanism of Human Red Blood Cell Longevity: Roles of Calcium, the Sodium Pump, PIEZO1, and Gardos Channels.
Lew V, Tiffert T
Front Physiol. 2018; 8:977.
PMID: 29311949
PMC: 5732905.
DOI: 10.3389/fphys.2017.00977.
ARHGAP18 is a novel gene under positive natural selection that influences HbF levels in β-thalassaemia.
He Y, Luo J, Chen Y, Zhou X, Yu S, Jin L
Mol Genet Genomics. 2017; 293(1):207-216.
PMID: 28983712
DOI: 10.1007/s00438-017-1377-2.
Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.
Jeney V
Front Pharmacol. 2017; 8:77.
PMID: 28270766
PMC: 5318432.
DOI: 10.3389/fphar.2017.00077.
Using Red Cell Indices and Reticulocyte Parameters for Carrier Screening of Various Thalassemia Syndromes.
Tangvarasittichai O, Poonanan N, Tangvarasittichai S
Indian J Clin Biochem. 2017; 32(1):61-67.
PMID: 28149014
PMC: 5247372.
DOI: 10.1007/s12291-016-0574-9.
